Fundraising FoxpHLIP
Kingston, US · Founded 2014 · Delaware corporation
Find your way into pHLIP
Sign up to see every warm intro you have to pHLIP
- Paths you didn't know you had: your email and LinkedIn already hold routes to the pHLIP team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
pHLIP Inc. develops a peptide-based targeted delivery platform (pHLIP, pH-Low Insertion Peptide) that selectively delivers therapeutic and imaging agents to acidic cells in diseased tissues. The technology targets cancer, inflammation, and other acidic tissue diseases by marking, reprogramming, or killing acidic cells.
Founders & leadership
pHLIP was founded in 2014 by OLEG A. ANDREEV, YANA K. RESHETNYAK, and DONALD ENGELMAN.
Reported raises · per SEC filings
Form D private placements$7.9M disclosed across 2 rounds · 2017–2018
▶$4.4MraisedOct 2018 · 5 investors · BiotechnologyRule 506(b)
- BRIAN NATHDirector
- JASON LEWISPromoter
- DANIEL GREENBERGDirector
- OLEG A. ANDREEVDirector
- DONALD ENGELMANDirector
- DOUGLAS KARPDirector
- YANA K. RESHETNYAKExecutive Officer, Director
- Offering amount
- $4.4M
- Amount sold
- $4.4M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$3.4MraisedSep 2017 · 5 investors · BiotechnologyRule 506(b)
- OLEG A. ANDREEVDirector
- JASON LEWISPromoter
- YANA K. RESHETNYAKExecutive Officer, Director
- DONALD ENGELMANDirector
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as pHLIP.
Frequently asked questions
- What does pHLIP do?
- pHLIP Inc. develops a peptide-based targeted delivery platform (pHLIP, pH-Low Insertion Peptide) that selectively delivers therapeutic and imaging agents to acidic cells in diseased tissues. The technology targets cancer, inflammation, and other acidic tissue diseases by marking, reprogramming, or killing acidic cells.
- Who founded pHLIP?
- pHLIP was founded by OLEG A. ANDREEV, YANA K. RESHETNYAK, DONALD ENGELMAN in 2014.
- How much funding has pHLIP raised?
- pHLIP has disclosed $7.9M raised across 2 rounds.
- Where is pHLIP headquartered?
- pHLIP is headquartered in Kingston, US.